Ribavirin Enhances the Action of Interferon-alpha against Hepatitis C Virus by Promoting the p53 Activity through the ERK1/2 Pathway
Resource
PLoS One, 7(9)
Journal
PLoS One
Journal Volume
7
Journal Issue
9
Pages
-
Date Issued
2012
Date
2012
Author(s)
Liu, Wei-Liang
Yang, Hung-Chih
Su, Wen-Cheng
Wang, Chih-Chiang
Chen, Hui-Ling
Wang, Hurng-Yi
Huang, Wen-Hung
Chen, Ding-Shinn
Lai, Ming-Yang
Abstract
Background/Aims: Ribavirin significantly enhances the antiviral response of interferon-alpha (IFN-alpha) against Hepatitis C virus (HCV), but the underlying mechanisms remain poorly understood. Recently, p53 has been identified as an important factor involving the suppression of HCV replication in hepatocytes. We, therefore, decided to investigate whether and how ribavirin inhibits the replication of HCV by promoting the activity of p53.
Methods: HepG2 and HCV replicons (JFH1/HepG2) were utilized to study the relationship between ribavirin and p53. The effect of ribavirin on cell cycles was analyzed by flow cytometry. The activation of p53 and the signaling pathways were determined using immunoblotting. By knocking down ERK1/ERK2 and p53 utilizing RNA interference strategy, we further assessed the role of ERK1/2 and p53 in the suppression of HCV replication by ribavirin in a HCV replicon system.
Results: Using HepG2 and HCV replicons, we demonstrated that ribavirin caused the cell cycle arrest at G1 phase and stabilized and activated p53, which was associated with the antiviral activity of ribavirin. Compared to either ribavirin or IFN-alpha alone, ribavirin plus IFN-alpha resulted in greater p53 activation and HCV suppression. We further identified ERK1/2 that linked ribavirin signals to p53 activation. More importantly, knockdown of ERK1/2 and p53 partially mitigated the inhibitory effects of ribavirin on the HCV replication, indicating that ERK1/2-p53 pathway was involved in the anti-HCV effects of ribavirin.
Conclusion: Ribavirin stimulates ERK1/2 and subsequently promotes p53 activity which at least partly contributes to the enhanced antiviral response of IFN-alpha plus ribavirin against HCV.
File(s)![Thumbnail Image]()
Loading...
Name
index.html
Size
23.18 KB
Format
HTML
Checksum
(MD5):a6d6c74b8d4ddce02feadb8122dc6901